Market revenue in 2023 | USD 1,345.8 million |
Market revenue in 2030 | USD 4,575.2 million |
Growth rate | 19.1% (CAGR from 2023 to 2030) |
Largest segment | Simple & peripheral elements |
Fastest growing segment | Simple & Peripheral Elements |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Simple & Peripheral Elements, Apparatus & Plants, Work Equipment |
Key market players worldwide | Sartorius AG, Danaher Corp, Thermo Fisher Scientific Inc, Merck KGaA, Avantor Inc, Eppendorf, Corning Inc, Lonza Group Ltd, PBS Biotech, Meissner |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single-use bioprocessing market will help companies and investors design strategic landscapes.
Simple & peripheral elements was the largest segment with a revenue share of 49.38% in 2023. Horizon Databook has segmented the Japan single-use bioprocessing market based on simple & peripheral elements, apparatus & plants, work equipment covering the revenue growth of each sub-segment from 2018 to 2030.
Japan represents a well-developed healthcare industry with significant involvement of government bodies for active promotion of biotechnology and related industries. The country is witnessing a demographic challenge as it is considered to have the oldest population in the world.
It acts as a catalyst and further drives the demand for biopharmaceutical development to ensure continuous medical supply. This, in turn, has resulted in the accelerated adoption of single-use technology.
Japan is one of the major Asian markets for single-use bioprocessing industry. Companies such as Takeda and Chugai are rapidly emerging in the field of biotech. For instance, in August 2020, Takeda announced a collaboration with Novavax for COVID-19 vaccine production in Japan for local commercialization.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan single-use bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into Japan single-use bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account